LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Immunology,Intensive Care and Hemostasis.
Number one in France and 5th in the world for plasma-derived medicinal products, the LFB group one also one of the leading European companies for the development and production of proteins and innovative treatments derived from biotechnologies.